{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:12:18Z","timestamp":1760015538087,"version":"build-2065373602"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,9]]},"DOI":"10.7759\/cureus.94194","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:31:34Z","timestamp":1760013094000},"source":"Crossref","is-referenced-by-count":0,"title":["Rogers Syndrome and Callosal Disconnection in the Setting of Moyamoya Disease"],"prefix":"10.7759","author":[{"given":"Carlos A","family":"Suanes Zubizarreta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aorzala","family":"Atmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grayson V","family":"Gigliotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina T","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Thiamine-responsive megaloblastic anemia syndrome","author":"Sako S","year":"2003","unstructured":"Sako S, Tsunogai T, Oishi K. Thiamine-responsive megaloblastic anemia syndrome. GeneReviews\u00ae. Adam MP, Mirzaa GM, Pagon RA, et al. (ed): University of Washington, Seattle, WA; 2003."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/10385","article-title":"Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome","volume":"22","author":"Diaz GA","year":"1999","unstructured":"Diaz GA, Banikazemi M, Oishi K, Desnick RJ, Gelb BD. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. Nat Genet. 1999, 22:309-12. 10.1038\/10385","journal-title":"Nat Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/ijpm.ijpm_287_23","article-title":"An extremely rare case of Rogers syndrome or thiamine responsive megaloblastic anemia","volume":"68","author":"Kaur G","year":"2025","unstructured":"Kaur G, Ahuja A, Sen A, Singhal P, Verghese R. An extremely rare case of Rogers syndrome or thiamine responsive megaloblastic anemia. Indian J Pathol Microbiol. 2025, 68:158-60. 10.4103\/ijpm.ijpm_287_23","journal-title":"Indian J Pathol Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00165-X","article-title":"Moyamoya disease: diagnosis and interventions","volume":"21","author":"Ihara M","year":"2022","unstructured":"Ihara M, Yamamoto Y, Hattori Y, et al.. Moyamoya disease: diagnosis and interventions. Lancet Neurol. 2022, 21:747-58. 10.1016\/S1474-4422(22)00165-X","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/STR.00000000000004","article-title":"Adult moyamoya disease and syndrome: current perspectives and future directions: a scientific statement from the American Heart Association\/American Stroke Association","volume":"54","author":"Gonzalez NR","year":"2023","unstructured":"Gonzalez NR, Amin-Hanjani S, Bang OY, et al.. Adult moyamoya disease and syndrome: current perspectives and future directions: a scientific statement from the American Heart Association\/American Stroke Association. Stroke. 2023, 54:465-79. 10.1161\/STR.00000000000004","journal-title":"Stroke"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2176\/jns-nmc.2022-0072","article-title":"Diagnostic criteria for moyamoya disease: 2021 revised version","volume":"62","author":"Kuroda S","year":"2022","unstructured":"Kuroda S, Fujimura M, Takahashi J, et al.. Diagnostic criteria for moyamoya disease: 2021 revised version. Neurol Med Chir (Tokyo). 2022, 62:307-12. 10.2176\/jns-nmc.2022-0072","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017701","article-title":"Association of antiplatelet therapy, including cilostazol, with improved survival in patients with moyamoya disease in a nationwide study","volume":"10","author":"Seo WK","year":"2021","unstructured":"Seo WK, Kim JY, Choi EH, et al.. Association of antiplatelet therapy, including cilostazol, with improved survival in patients with moyamoya disease in a nationwide study. J Am Heart Assoc. 2021, 10:e017701. 10.1161\/JAHA.120.017701","journal-title":"J Am Heart Assoc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2176\/jns-nmc.2021-0382","article-title":"2021 Japanese guidelines for the management of moyamoya disease: guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society","volume":"62","author":"Fujimura M","year":"2022","unstructured":"Fujimura M, Tominaga T, Kuroda S, Takahashi JC, Endo H, Ogasawara K, Miyamoto S. 2021 Japanese guidelines for the management of moyamoya disease: guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society. Neurol Med Chir (Tokyo). 2022, 62:165-70. 10.2176\/jns-nmc.2021-0382","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-022-05255-1","article-title":"How I do it: superficial temporal artery to middle cerebral artery bypass for moyamoya disease","volume":"164","author":"Liao Y","year":"2022","unstructured":"Liao Y, Xu F, Xu B. How I do it: superficial temporal artery to middle cerebral artery bypass for moyamoya disease. Acta Neurochir (Wien). 2022, 164:1855-9. 10.1007\/s00701-022-05255-1","journal-title":"Acta Neurochir (Wien)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.07.088","article-title":"Improving indirect revascularization for effective treatment of adult moyamoya disease: a prospective clinical, cerebral angiographic, and perfusion study","volume":"119","author":"Chou SC","year":"2018","unstructured":"Chou SC, Chen YF, Lee CW, et al.. Improving indirect revascularization for effective treatment of adult moyamoya disease: a prospective clinical, cerebral angiographic, and perfusion study. World Neurosurg. 2018, 119:e180-91. 10.1016\/j.wneu.2018.07.088","journal-title":"World Neurosurg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18203\/2349-3291.ijcp20231510","article-title":"Roger\u2019s syndrome presenting with stroke","volume":"10","author":"Kataria B","year":"2023","unstructured":"Kataria B, Patra B, Chumber S, Vani K. Roger\u2019s syndrome presenting with stroke. Int J Contemp Pediatr. 2023, 10:962-5. 10.18203\/2349-3291.ijcp20231510","journal-title":"Int J Contemp Pediatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/411676-rogers-syndrome-and-callosal-disconnection-in-the-setting-of-moyamoya-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:31:35Z","timestamp":1760013095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/411676-rogers-syndrome-and-callosal-disconnection-in-the-setting-of-moyamoya-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.94194","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}